In this interview, Frank Fischer and Martha Morrell, MD, recount the long history of NeuroPace, one of Medtech’s neurostimulation pioneers.
Bio Coming Soon.
Martha Morrell, MD
Chief Medical Officer
Dr. Morrell became Chief Medical Officer of NeuroPace, Inc. in July 2004, as well as a Clinical Professor of Neurology at Stanford University. Before joining NeuroPace, she was the Caitlin Tynan Doyle Professor of Clinical Neurology at Columbia University and Director of the Columbia Comprehensive Epilepsy Center at New York Presbyterian Hospital in New York City.
Previously she was on the faculty of the Stanford University School of Medicine where she served as Director of the Stanford Comprehensive Epilepsy Center. A graduate of Stanford Medical School, she completed residency training in Neurology at University of Pennsylvania, as well as fellowship training in EEG and epilepsy. Dr. Morrell’s clinical and research work has been directed to the care of people with epilepsy.
She has more than 150 publications on epilepsy and has spoken extensively on epilepsy nationally as well as internationally. She has been a member of the Board of Directors of the American Epilepsy Society and a member and Chair of the Board of the Epilepsy Foundation.
Service to other professional societies includes the American Neurological Association as a member of the Council and the American Academy of Neurology as Chair of the Epilepsy Section. She is an elected Ambassador for Epilepsy of the International League Against Epilepsy and received the American Epilepsy Society’s 2007 Service Award for outstanding leadership and service. She is incoming President of the American Society for Experimental NeuroTherapeutics.
Meet Our Host
A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.